The safety and efficacy of TACE combined with HAIC, PD-1 inhibitors, and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a retrospective study

The safety and efficacy of TACE combined with HAIC, PD-1 inhibitors, and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a retrospective study

ObjectiveTo assess the effectiveness and safety of transarterial chemoembolization (TACE) in combination with hepatic artery infusion chemotherapy (HAIC)、PD-1 inhibitors, and tyrosine kinase inhibitors(TKI) for unresectable hepatocellular carcinoma (HCC).MethodsA retrospective analysis was performed...

Full description

Bibliographic Details
Main Authors: Zhongjing Huang, Ziyi Wu, Lidong Zhang, Likun Yan, Hai Jiang, Junhua Ai
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
transarterial chemoembolization
immunotherapy
hepatic artery infusion chemotherapy
targeted therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1298122/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1298122/full

Similar Items